Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record.

NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects

DAVIES, N. M., RØSETH, A. G., APPLEYARD, C. B., MCKNIGHT, W., DEL SOLDATO, P., CALIGNANO, A., CIRINO, G., WALLACE, J. L. · 1997 · Alimentary Pharmacology & Therapeutics

Abstract

Background: A novel class of nitric oxide‐releasing nonsteroidal anti‐inflammatory drug (NO‐NSAID) derivatives has recently been described which exert anti‐inflammatory activities but produce significantly less gastrointestinal injury than the parent NSAID from which they are derived. The present studies were performed to determine if a nitroxybutylester derivative of naproxen was less ulcerogenic to the gastrointestinal tract than its parent NSAID, and if it exerted comparable analgesic and anti‐inflammatory properties to the parent NSAID. Methods: The two drugs were compared in an acute gastric injury model, an antral ulcer model and after twice‐daily administration for 18 days (small intestinal damage model). Anti‐inflammatory activity was examined in the carrageenan‐induced paw oedema model, while analgesia was examined in the acetic acid‐induced writhing model. The pharmacokinetic profiles of naproxen vs. NO‐naproxen were compared by HPLC analysis. Results: NO‐naproxen was found to produce significantly less gastric damage despite inducing similar increases in plasma TNFα to naproxen. With chronic administration, small intestinal damage was markedly less with NO‐naproxen than with the parent NSAID. However, NO‐naproxen exerted superior analgesic and comparable anti‐inflammatory effects to naproxen. NO‐naproxen was not completely converted to naproxen, but the reduced plasma levels of the latter was not the underlying reason for reduced gastrointestinal toxicity of NO‐naproxen. Conclusion: NO‐naproxen represents a novel, gastrointestinal‐sparing NSAID derivative with superior analgesic and comparable anti‐inflammatory properties to naproxen.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1997.115286000.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
DAVIES, N. M., RØSETH, A. G., APPLEYARD, C. B., MCKNIGHT, W., DEL SOLDATO, P., CALIGNANO, A., CIRINO, G., & WALLACE, J. L.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1997-02
Volume
11
Issue
1
Pages
69-79
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2077502100
Cited by
185
References
0
FWCI
10.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects. https://app.cochat.ai/papers/10.1046/j.1365-2036.1997.115286000.x
The paper
DAVIES, N. M., RØSETH, A. G., APPLEYARD, C. B., MCKNIGHT, W., DEL SOLDATO, P., CALIGNANO, A., CIRINO, G., & WALLACE, J. L. (1997). NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1997.115286000.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.